β2-adrenoreceptors of regulatory lymphocytes are essential for vagal neuromodulation of the innate immune system

FASEB Journal

Volumn 25, Issue 12, 2011, Pages 4476-4485

  Vida, Gergely ^a   Peña, Geber ^a   Kanashiro, Alexandre ^a   Thompson Bonilla, Maria Del Rocio ^a   Palange, David ^a   Deitch, Edwin A ^a   Ulloa, Luis ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Cytokine; Inflammation; Parasympathetic nervous system; Sepsis; Septic; Shock; Vagus nerve

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; LIPOPOLYSACCHARIDE; NORADRENALIN; SALBUTAMOL; TERBUTALINE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; ENDOTOXEMIA; INFLAMMATION; INNATE IMMUNITY; MOUSE; NEUROMODULATION; NONHUMAN; ORGAN INJURY; PERITONITIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SEPTIC SHOCK; SPLEEN CELL; VAGUS NERVE;

ANIMALS; CYTOKINES; ENDOTOXEMIA; HEMODYNAMICS; IMMUNITY, INNATE; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, NUDE; NEUROIMMUNOMODULATION; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-2; SEPSIS; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA; VAGUS NERVE;

EID: 82655181506     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-191007     Document Type: Article

References (57)

1. Nathan, C. (2002) Points of control in inflammation. Nature 420, 846-852
2. Ulloa, L. (2005) The vagus nerve and the nicotinic antiinflammatory pathway. Nat. Rev. 4, 673-684
3. Ulloa, L., and Tracey, K. J. (2005) The "cytokine profile": a code for sepsis. Trends Mol. Med. 11, 56-63
4. Sands, K. E., Bates, D. W., Lanken, P. N., Graman, P. S., Hibberd, P. L., Kahn, K. L., Parsonnet, J., Panzer, R., Orav, E. J., and Snydman, D. R. (1997) Epidemiology of sepsis syndrome in 8 academic medical centers. Academic Medical Center Consortium Sepsis Project Working Group. JAMA 278, 234-240
5. Angus, D. C. (2007) Caring for the critically ill patient: challenges and opportunities. JAMA 298, 456-458
6. Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., and Pinsky, M. R. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29, 1303-1310 (Pubitemid 32641789)
7. Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., and Cerami, A. (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330, 662-664 (Pubitemid 18005583)
8. Riedemann, N. C., Guo, R. F., and Ward, P. A. (2003) Novel strategies for the treatment of sepsis. Nat. Med. 9, 517-524 (Pubitemid 36597096)
9. Ulloa, L., Brunner, M., Ramos, L., and Deitch, E. A. (2009) Scientific and clinical challenges in sepsis. Curr. Pharm. Des. 15, 1918-1935
10. Abraham, E., Laterre, P. F., Garbino, J., Pingleton, S., Butler, T., Dugernier, T., Margolis, B., Kudsk, K., Zimmerli, W., Anderson, P., Reynaert, M., Lew, D., Lesslauer, W., Passe, S., Cooper, P., Burdeska, A., Modi, M., Leighton, A., Salgo, M., and Van der Auwera, P. (2001) Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients. Crit. Care Med. 29, 503-510 (Pubitemid 32225290)
11. Steinman, L. (2004) Elaborate interactions between the immune and nervous systems. Nat. Immunol. 5, 575-581
12. Sternberg, E. M. (2006) Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat. Rev. Immunol. 6, 318-328
13. Tracey, K. J. (2009) Reflex control of immunity. Nat. Rev. Immunol. 9, 418-428
14. Tracey, K. J. (2010) Understanding immunity requires more than immunology. Nat. Immunol. 11, 561-564
15. Huston, J. M., Ochani, M., Rosas-Ballina, M., Liao, H., Ochani, K., Pavlov, V. A., Gallowitsch-Puerta, M., Ashok, M., Czura, C. J., Foxwell, B., Tracey, K. J., and Ulloa, L. (2006) Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J. Exp. Med. 203, 1623-1628
16. Bernik, T. R., Friedman, S. G., Ochani, M., DiRaimo, R., Susarla, S., Czura, C. J., and Tracey, K. J. (2002) Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J. Vasc. Surg. 36, 1231-1236 (Pubitemid 36236348)
17. Altavilla, D., Guarini, S., Bitto, A., Mioni, C., Giuliani, D., Bigiani, A., Squadrito, G., Minutoli, L., Venuti, F. S., Messineo, F., De Meo, V., Bazzani, C., and Squadrito, F. (2006) Activation of the cholinergic anti-inflammatory pathway reduces NF-kappab activation, blunts TNF-alpha production, and protects againts splanchic artery occlusion shock. Shock 25, 500-506
18. Cai, B., Chen, F., Ji, Y., Kiss, L., DeJonge, W., Szabo, C., Deitch, E., and Ulloa, L. (2009) Alpha7 cholinergic-agonist prevents systemic inflammation and improves survival during resuscitation. J. Cell. Mol. Med. 13, 3774-3785
19. Van Westerloo, D. J., Giebelen, I. A., Florquin, S., Bruno, M. J., Larosa, G. J., Ulloa, L., Tracey, K. J., and van der Poll, T. (2006) The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 130, 1822-1830
20. Pullan, R. D., Rhodes, J., Ganesh, S., Mani, V., Morris, J. S., Williams, G. T., Newcombe, R. G., Russell, M. A., Feyerabend, C., Thomas, G. A., and Sawe, U. (1994) Transdermal nicotine for active ulcerative colitis. N. Engl. J. Med. 330, 811-815 (Pubitemid 24083559)
21. Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., Wang, H., Abumrad, N., Eaton, J. W., and Tracey, K. J. (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405, 458-462 (Pubitemid 30367422)
22. Wang, H., Liao, H., Ochani, M., Justiniani, M., Lin, X., Yang, L., Al-Abed, Y., Wang, H., Metz, C., Miller, E. J., Tracey, K. J., and Ulloa, L. (2004) Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 10, 1216-1221 (Pubitemid 39540438)
23. Van Westerloo, D. J., Giebelen, I. A., Florquin, S., Daalhuisen, J., Bruno, M. J., de Vos, A. F., Tracey, K. J., and van der Poll, T. (2005) The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J. Infect. Dis. 191, 2138-2148 (Pubitemid 40800586)
24. De Jonge, W. J., and Ulloa, L. (2007) The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Brit. J. Pharmacol. 151, 915-929 (Pubitemid 47195518)
25. Bernik, T. R., Friedman, S. G., Ochani, M., DiRaimo, R., Ulloa, L., Yang, H., Sudan, S., Czura, C. J., Ivanova, S. M., and Tracey, K. J. (2002) Pharmacological stimulation of the cholinergic antiinflammatory pathway. J. Exp. Med. 195, 781-788 (Pubitemid 34259722)
26. Flood, J. F., Smith, G. E., and Morley, J. E. (1987) Modulation of memory processing by cholecystokinin: dependence on the vagus nerve. Science 236, 832-834 (Pubitemid 17071160)
27. Vida, G., Peña, G., Deitch, E. A., and Ulloa, L. (2011) Alpha7-nicotinic receptor mediates vagal induction of splenic norepinephrine. J. Immunol. 186, 4340-4346
28. Chruscinski, A. J., Rohrer, D. K., Schauble, E., Desai, K. H., Bernstein, D., and Kobilka, B. K. (1999) Targeted disruption of the beta2 adrenergic receptor gene. J. Biol. Chem. 274, 16694-16700
29. Oberbeck, R., and Kobbe, P. (2009) Beta-adrenergic antagonists: indications and potential immunomodulatory side effects in the critically ill. Curr. Med. Chem. 16, 1082-1090
30. Crassous, P. A., Denis, C., Paris, H., and Senard, J. M. (2007) Interest of alpha2-adrenergic agonists and antagonists in clinical practice: background, facts and perspectives. Curr. Top. Med. Chem. 7, 187-194 (Pubitemid 46062389)
31. De Montmollin, E., Aboab, J., Mansart, A., and Annane, D. (2009) Bench-to-bedside review: Beta-adrenergic modulation in sepsis. [Online] Crit. Care 13, 230
32. Javed, U., and Deedwania, P. C. (2009) Beta-adrenergic blockers for chronic heart failure. Cardiol. Rev. 17, 287-292
33. Ortega, V. E., and Peters, S. P. (2010) Beta-2 adrenergic agonists: focus on safety and benefits versus risks. Curr. Opin. Pharmacol. 10, 246-253
34. Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., Manogue, K. R., Faist, E., Abraham, E., Andersson, J., Andersson, U., Molina, P. E., Abumrad, N. N., Sama, A., and Tracey, K. J. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285, 248-251 (Pubitemid 29329996)
35. Lotze, M. T., and Tracey, K. J. (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5, 331-342 (Pubitemid 40516158)
36. Ulloa, L., and Messmer, D. (2006) High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev. 17, 189-201 (Pubitemid 43949075)
37. Mebius, R. E., and Kraal, G. (2005) Structure and function of the spleen. Nat. Rev. Immunol. 5, 606-616 (Pubitemid 41113192)
38. Felten, D. L., Felten, S. Y., Bellinger, D. L., Carlson, S. L., Ackerman, K. D., Madden, K. S., Olschowki, J. A., and Livnat, S. (1987) Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunol. Rev. 100, 225-260 (Pubitemid 18017643)
39. Felten, S. Y., Madden, K. S., Bellinger, D. L., Kruszewska, B., Moynihan, J. A., and Felten, D. L. (1998) The role of the sympathetic nervous system in the modulation of immune responses. Adv. Pharmacol. 42, 583-587
40. Straub, R. H., Westermann, J., Scholmerich, J., and Falk, W. (1998) Dialogue between the CNS and the immune system in lymphoid organs. Immunol. Today 19, 409-413 (Pubitemid 28389702)
41. Crandall, M., Shapiro, M. B., and West, M. A. (2009) Does splenectomy protect against immune-mediated complications in blunt trauma patients? Mol. Med. 15, 263-267
42. Rosas-Ballina, M., Ochani, M., Parrish, W. R., Ochani, K., Harris, Y. T., Huston, J. M., Chavan, S., and Tracey, K. J. (2008) Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc. Natl. Acad. Sci. U. S. A. 105, 11008-11013
43. Kobilka, B. (1992) Adrenergic receptors as models for G protein-coupled receptors. Annu. Rev. Neurosci. 15, 87-114
44. Small, K. M., McGraw, D. W., and Liggett, S. B. (2003) Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu. Rev. Pharmacol. Toxicol. 43, 381-411 (Pubitemid 37372647)
45. Sanders, V. M., and Kavelaars, A. (2007) Adrenergic regulation of immunity. Phychoneuroimmunology 1, 63-83
46. Levine, J. D., Coderre, T. J., Helms, C., and Basbaum, A. I. (1988) Beta 2-adrenergic mechanisms in experimental arthritis. Proc. Natl. Acad. Sci. U. S. A. 85, 4553-4556
47. van der Poll, T., Jansen, J., Endert, E., Sauerwein, H. P., and van Deventer, S. J. (1994) Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect. Immun. 62, 2046-2050 (Pubitemid 24137012)
48. Wang, H., Yu, M., Ochani, M., Amella, C. A., Tanovic, M., Susarla, S., Li, J. H., Wang, H., Yang, H., Ulloa, L., Al-Abed, Y., Czura, C. J., and Tracey, K. J. (2003) Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421, 384-388 (Pubitemid 36157937)
49. Venet, F., Chung, C. S., Monneret, G., Huang, X., Horner, B., Garber, M., and Ayala, A. (2008) Regulatory T-cell populations in sepsis and trauma. J. Leukocyte Biol. 83, 523-535 (Pubitemid 351966861)
50. O'Mahony, C., van der Kleij, H., Bienenstock, J., Shanahan, F., and O'Mahony, L. (2009) Loss of vagal anti-inflammatory effect: in vivo visualization and adoptive transfer. Am. J. Physiol. Regul. Integr. Comp. Physiol. 297, R1118-R1126
51. Hasko, G., Szabo, C., Nemeth, Z. H., Salzman, A. L., and Vizi, E. S. (1998) Stimulation of beta-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice. J. Neuroimmunol. 88, 57-61 (Pubitemid 28342903)
52. Eijkelkamp, N., Cobelens, P. M., Sanders, V. M., Heijnen, C. J., and Kavelaars, A. (2004) Tissue-specific effects of the beta 2-adrenergic agonist salbutamol on LPS-induced IFN-gamma, IL-10 and TGF-beta responses in vivo. J. Neuroimmunol. 150, 3-9 (Pubitemid 38481642)
53. Nakamura, A., Imaizumi, A., Yanagawa, Y., Kohsaka, T., and Johns, E. J. (2004) beta(2)-Adrenoceptor activation attenuates endotoxin-induced acute renal failure. J. Am. Soc. Nephrol. 15, 316-325 (Pubitemid 38140772)
54. Nakada, T. A., Russell, J. A., Boyd, J. H., Aguirre-Hernandez, R., Thain, K. R., Thair, S. A., Nakada, E., McConechy, M., and Walley, K. R. (2010) β2-Adrenergic receptor gene polymorphism is associated with mortality in septic shock. Am. J. Respir. Crit. Care. Med. 181, 143-149
55. Seong, S. Y., and Matzinger, P. (2004) Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4, 469-478
56. Eskandari, M. K., Bolgos, G., Miller, C., Nguyen, D. T., DeForge, L. E., and Remick, D. G. (1992) Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J. Immunol. 148, 2724-2730
57. Calandra, T., Echtenacher, B., Roy, D. L., Pugin, J., Metz, C. N., Hultner, L., Heumann, D., Mannel, D., Bucala, R., and Glauser, M. P. (2000) Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat. Med. 6, 164-170 (Pubitemid 30082360)